Genital Neoplasms, Female

2

Review clinical trials related to Genital Neoplasms, Female. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Patient Journey in Advanced Gynecologic Cancers

This is a mixed-methods survey study including a 2-phased sequential-explanatory design. This study is to understand the patient journey in conventional therapy for newly diagnosed stage III or IV CC or EC in China, including ①patients' treatment decision making factors and treatment experiences and ② patients' unmet needs during post-treatment surveillance.

Participants needed: 780
Trial details
Age: 18+Biological sex: FemaleType: ObservationalSponsor: Tongji HospitalUpdated: Jun 11, 2025Locations: 4Duration: 1 Day
Eligibility criteria

Age 18 or older [+4]

Previously treated with targeted biologic therapy anti-PD-1, anti-PD-L1, or anti... [+5]

Status: Recruiting

Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer

This is a study of pembrolizumab (MK-3475, KEYTRUDA®) in combination with lenvatinib (E7080) for the treatment of platinum sensitive recurrent ovarian cancer. Participants will receive pembrolizumab and lenvatinib.

Participants needed: 24
Trial details
Phase: Phase 2Age: 18+Biological sex: FemaleType: InterventionalSponsor: Sheba Medical CenterUpdated: Jun 8, 2023Locations: 1
Eligibility criteria

Female participants who are at least 18 years of age on the day of signing infor... [+6]

A WOCBP who has a positive urine pregnancy test [+31]